Glaxosmithkline Share News (GSK)

UK earnings, trading statements calendar - next 7 days

European shares rebound on earnings boost

April 20 (Reuters) - A clutch of positive earnings including from chipmaker ASML and consumer stock Danone, helped European shares rebound on Wednesday, although worries over the Ukraine-Russia war, slowing growth and rising yields kept gains in check.

Drugmaker GlaxoSmithKline faces strike over "derisory" pay offer

(Alliance News) - Hundreds of UK workers at pharmaceutical giant GlaxoSmithKline PLC are set to strike over a "derisory" pay offer way below the level of British inflation, a union said Wednesday.

GlaxoSmithKline says FDA accepts application for kidney disease drug

(Alliance News) - GlaxoSmithKline PLC on Tuesday said the US Food & Drug Administration has accepted the company's application for the review of kidney disease drug daprodustat.

US FDA accepts GSK application for kidney disease drug

(Sharecast News) - GlaxoSmithKline said the US Food and Drug Administration (FDA) had accepted its application for its chronic kidney disease drug daprodustat.

LONDON BROKER RATINGS: BofA raises Rightmove; Berenberg cuts Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday afternoon:

TRADING UPDATES: Sureserve gets new CFO; Sareum notes GSK buys Sierra

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

LONDON MARKET MIDDAY: Miners keep FTSE 100 afloat after hot inflation

(Alliance News) - The FTSE 100 was treading water around midday on Wednesday, following the third straight extraordinary inflation print of the week.

GSK to buy Sierra Oncology amid pressure to boost drug pipeline

April 13 (Reuters) - Britain's GlaxoSmithKline sought to bolster its cancer business on Wednesday by agreeing a $1.9 billion deal to buy U.S. drug developer Sierra Oncology , the latest move to fend off pressure from activist shareholder Elliott.

TOP NEWS: GlaxoSmithKline to buy Sierra Oncology for USD1.9 billion

(Alliance News) - GlaxoSmithKline PLC on Wednesday said it reached an agreement to acquire late-stage biopharmaceutical company Sierra Oncology Inc for USD1.9 billion, or GBP1.5 billion.

LONDON MARKET PRE-OPEN: UK inflation rips to 30-year high; GSK buys

(Alliance News) - Stocks in London were called flat on Wednesday morning as investors digest surging UK inflation data, which follows on the heels of red-hot consumer prices in the US and Germany.

GSK agrees to buy Sierra Oncology for $1.9bn

(Sharecast News) - GlaxoSmithKline has agreed to buy Sierra Oncology, a US rare cancer therapy company, for $1.9bn (£1.5bn) in cash to add to its roster of specialty medicines and vaccines.

LONDON BROKER RATINGS: Jefferies raises John Wood; Investec cuts Metro

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

British drugmaker GSK stops supplement, vitamin sales to Russia

April 6 (Reuters) - GlaxoSmithKline said on Wednesday its consumer arm has stopped shipments of supplements and vitamins to Russia as a result of Moscow's invasion of Ukraine and would prioritise the supply of over-the-counter medicines for basic needs.

FTSE 100 rises on healthcare, utilities boost

April 5 (Reuters) - London's FTSE 100 index edged higher on Tuesday powered by healthcare and utility stocks, while investors closely tracked the prospect of more Western sanctions against Russia over the war in Ukraine.